Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Teva and IBM have formed a three-year, Watson-enabled drug repurposing collaboration
Ginkgo Bioworks has teamed up with Prospect Bio to incorporate biosensors into its organism design process.
Insmed aims to bring a first-in-market therapy to patients in the U.S. suffering from NTM lung disease caused by MAC, a chronic and debilitating condition.
A team of clinical trial tech veterans has raised $5 million to fund development and early marketing of a randomization and trial supply management system.
Organ-on-a-chip player Emulate has added $17 million to its Series B round and landed a deal with Covance.
A council chaired by President Obama has called for countries to cooperate to investigate the potential uses of artificial intelligence in healthcare.
Elemental Machines is shipping its sensor-enabled smart lab system to cut the time it takes to pinpoint causes of variability and reproducibility problems.
Amadeus Capital and Jonathan Milner have teamed up to invest in Healx, a startup working with patient advocacy groups to repurpose drugs for rare diseases.
Recursion Pharmaceuticals has raised $12.9 million to scale up its computer-driven approach to drug development.
UC San Francisco has landed $24 million in National Science Foundation funding to set up the Center for Cellular Construction.
British startup BenevolentAI has become the first European firm to install a purpose-built version of the DGX-1, a supercomputer designed for deep learning.